<DOC>
	<DOCNO>NCT00689520</DOCNO>
	<brief_summary>The purpose study evaluate whether low-molecular-weight heparin could equally effective oral anticoagulation long-term treatment deep venous thrombosis .</brief_summary>
	<brief_title>Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants Deep Venous Thrombosis</brief_title>
	<detailed_description>The open-label prospective randomize clinical trial compare subcutaneous LMWH ( tinzaparin ) administer 6 month versus initial treatment use subcutaneous LMWH follow oral anticoagulant give similar period time patient proximal venous thrombosis .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin K</mesh_term>
	<mesh_term>Tinzaparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<mesh_term>Acenocoumarol</mesh_term>
	<criteria>Consecutive , symptomatic patient first recurrent episode acute proximalvein thrombosis low limb . either sex 18 year age refer Vascular Surgery Department hospital onset symptom less 2 week document compression ultrasonography , receive heparin , lowmolecularweight heparin oral anticoagulant therapy 2 day present disease pulmonary embolism require thrombolytic therapy Need surgical thrombectomy vena cava interruption receive oral anticoagulant treatment antiplatelet agent condition contraindication anticoagulant treatment ( active bleeding , severe blood pressure allergy study drug ) platelet count low 100x103 /Î¼l hemoglobin concentration lower 7 g/dl history heparinassociated thrombocytopenia severe renal failure necessitate dialysis pregnancy lumbar puncture within previous 24 hour</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Venous thromboembolism</keyword>
	<keyword>low molecular weight heparin</keyword>
	<keyword>Vitamin K antagonist</keyword>
	<keyword>Longterm</keyword>
</DOC>